386 related articles for article (PubMed ID: 18618481)
1. A critical evaluation of drug interactions with Echinacea spp.
Freeman C; Spelman K
Mol Nutr Food Res; 2008 Jul; 52(7):789-98. PubMed ID: 18618481
[TBL] [Abstract][Full Text] [Related]
2. The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo.
Gorski JC; Huang SM; Pinto A; Hamman MA; Hilligoss JK; Zaheer NA; Desai M; Miller M; Hall SD
Clin Pharmacol Ther; 2004 Jan; 75(1):89-100. PubMed ID: 14749695
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of echinacea (Echinacea angustafolia, e. purpurea and e. pallida) during pregnancy and lactation.
Perri D; Dugoua JJ; Mills E; Koren G
Can J Clin Pharmacol; 2006; 13(3):e262-7. PubMed ID: 17085774
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 inhibitory action of Echinacea preparations differs widely and co-varies with alkylamide content.
Modarai M; Gertsch J; Suter A; Heinrich M; Kortenkamp A
J Pharm Pharmacol; 2007 Apr; 59(4):567-73. PubMed ID: 17430641
[TBL] [Abstract][Full Text] [Related]
5. Echinacea purpurea and P-glycoprotein drug transport in Caco-2 cells.
Hansen TS; Nilsen OG
Phytother Res; 2009 Jan; 23(1):86-91. PubMed ID: 18688789
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic herb-drug interactions: are preventive screenings necessary and appropriate?
Butterweck V; Derendorf H; Gaus W; Nahrstedt A; Schulz V; Unger M
Planta Med; 2004 Sep; 70(9):784-91. PubMed ID: 15386186
[TBL] [Abstract][Full Text] [Related]
7. The effect of standardized Echinacea purpurea extract on rat cytochrome P450 expression level.
Mrozikiewicz PM; Bogacz A; Karasiewicz M; Mikolajczak PL; Ozarowski M; Seremak-Mrozikiewicz A; Czerny B; Bobkiewicz-Kozlowska T; Grzeskowiak E
Phytomedicine; 2010 Aug; 17(10):830-3. PubMed ID: 20374973
[TBL] [Abstract][Full Text] [Related]
8. Herbal extracts used for upper respiratory tract infections: are there clinically relevant interactions with the cytochrome P450 enzyme system?
Heinrich M; Modarai M; Kortenkamp A
Planta Med; 2008 May; 74(6):657-60. PubMed ID: 18584812
[TBL] [Abstract][Full Text] [Related]
9. P-Glycoprotein inhibitory activity of lipophilic constituents of Echinacea pallida roots in a human proximal tubular cell line.
Romiti N; Pellati F; Nieri P; Benvenuti S; Adinolfi B; Chieli E
Planta Med; 2008 Feb; 74(3):264-6. PubMed ID: 18425719
[TBL] [Abstract][Full Text] [Related]
10. Herbal remedies in the United States: potential adverse interactions with anticancer agents.
Sparreboom A; Cox MC; Acharya MR; Figg WD
J Clin Oncol; 2004 Jun; 22(12):2489-503. PubMed ID: 15197212
[TBL] [Abstract][Full Text] [Related]
11. Adverse interactions between herbal and dietary substances and prescription medications: a clinical survey.
Bush TM; Rayburn KS; Holloway SW; Sanchez-Yamamoto DS; Allen BL; Lam T; So BK; Tran de H; Greyber ER; Kantor S; Roth LW
Altern Ther Health Med; 2007; 13(2):30-5. PubMed ID: 17405676
[TBL] [Abstract][Full Text] [Related]
12. Identification and exploration of herb-drug combinations used by cancer patients.
Engdal S; Klepp O; Nilsen OG
Integr Cancer Ther; 2009 Mar; 8(1):29-36. PubMed ID: 19174505
[TBL] [Abstract][Full Text] [Related]
13. In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto.
Gurley BJ; Gardner SF; Hubbard MA; Williams DK; Gentry WB; Carrier J; Khan IA; Edwards DJ; Shah A
Clin Pharmacol Ther; 2004 Nov; 76(5):428-40. PubMed ID: 15536458
[TBL] [Abstract][Full Text] [Related]
14. Clinical evidence of herbal drugs as perpetrators of pharmacokinetic drug interactions.
Hermann R; von Richter O
Planta Med; 2012 Sep; 78(13):1458-77. PubMed ID: 22855269
[TBL] [Abstract][Full Text] [Related]
15. Metabolomic profiling of liquid Echinacea medicinal products with in vitro inhibitory effects on cytochrome P450 3A4 (CYP3A4).
Modarai M; Yang M; Suter A; Kortenkamp A; Heinrich M
Planta Med; 2010 Mar; 76(4):378-85. PubMed ID: 19790031
[TBL] [Abstract][Full Text] [Related]
16. [Echinacea drugs--effects and active ingredients].
Bauer R
Z Arztl Fortbild (Jena); 1996 Apr; 90(2):111-5. PubMed ID: 8686333
[TBL] [Abstract][Full Text] [Related]
17. Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt.,Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties.
Barnes J; Anderson LA; Gibbons S; Phillipson JD
J Pharm Pharmacol; 2005 Aug; 57(8):929-54. PubMed ID: 16102249
[TBL] [Abstract][Full Text] [Related]
18. Echinacea.
Kligler B
Am Fam Physician; 2003 Jan; 67(1):77-80. PubMed ID: 12537169
[TBL] [Abstract][Full Text] [Related]
19. Review and Assessment of Medicinal Safety Data of Orally Used Echinacea Preparations.
Ardjomand-Woelkart K; Bauer R
Planta Med; 2016 Jan; 82(1-2):17-31. PubMed ID: 26441065
[TBL] [Abstract][Full Text] [Related]
20. Prediction of herb-drug metabolic interactions: a simulation study.
Zhou S; Huang M; Xu A; Yang H; Duan W; Paxton JW
Phytother Res; 2005 Jun; 19(6):464-71. PubMed ID: 16114078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
